Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00930059

Public ClinicalTrials.gov record NCT00930059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2 MULTICENTER, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY OF PF-04447943 IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effects of PF-04447943 compared to placebo on cognitive, behavioral and overall symptoms of Alzheimer's disease; evaluate the safety and tolerability of PF-0444793 compared to placebo; and determine the levels of PF-04447943 in the plasma over the course of the study.

Study identification

NCT ID
NCT00930059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
191 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2009 (Actual)
Primary completion
Sep 22, 2010 (Actual)
Completion
Sep 22, 2010 (Actual)
Last update posted
Nov 19, 2020

2009 – 2010

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Neurology Clinic, PC Northport Alabama 35476 —
ATP Clinical Research, Inc. Costa Mesa California 92626 —
Southwestern Research Incorporated Glendale California 91204 —
Pacific Coast Imaging (for Imaging only) Newport Beach California 92663 —
The Southwest Institute for Clinical Research, Inc. Rancho Mirage California 92270 —
Pacific Research Network (Satellite Site) San Diego California 92128 —
Pacific Research Network, Inc. (Satellite Site) Vista California 92081 —
MD Clinical Hallandale Florida 33009 —
Compass Research, LLC Orlando Florida 32806 —
Berma Research Group Plantation Florida 33317 —
Joliet Center for Clinical Research Joliet Illinois 60435 —
Fort Wayne Neurological Center Fort Wayne Indiana 46805 —
Agewell Indianapolis Indiana 46260 —
Four Rivers Clinical Research, Inc. Paducah Kentucky 42003 —
Advanced MRI Lake Charles Louisiana 70601 —
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70601 —
Neurocare, Inc. Newton Massachusetts 02459 —
Neurobehavioral Research Inc Cedarhurst New York 11516 —
Behavioral Medical Research of Staten Island Staten Island New York 10305 —
University of Pittsburgh Alzheimer's Disease Research Center Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital, Alzheimer's Disease and Memory Disorders Center Providence Rhode Island 02903 —
Neurology Clinic, PC Cordova Tennessee 38018 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00930059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2020 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00930059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →